ABSTRACT NUMBER: ESOC2026YS109 PROGNOSTIC IMPACT OF SEQUENTIAL SERUM BIOMARKERS AND MULTIMODAL CT IMAGING ON CLINICAL OUTCOMES AFTER EXTENDED-WINDOW MECHANICAL THROMBECTOMY IN ACUTE ISCHEMIC STROKE

Abstract Background and aims Clinical outcome prognostic of acute ischemic stroke (AIS) patients undergoing mechanical thrombectomy (MT) beyond 6 hours from symptom onset remains challenging. While multimodal CT provides valuable information about brain parenchyma status, biological processes such as inflammation, hemostatic disturbances, and blood–brain barrier disruption may influence outcomes. The role of sequential serum biomarker monitoring in this context is not fully determined. The aim of the study is to assess whether dynamic changes in serum biomarkers, particularly matrix metalloproteinase-9 (MMP-9), alongside multimodal CT imaging, could improve prognostic evaluation of AIS patients undergoing MT in the extended window (6–24 hours). Methods The ongoing prospective observational study includes AIS patients treated with MT at a comprehensive stroke center. Baseline multimodal CT (non-contrast CT, CT angiography, CT perfusion) is used to characterize ischemic core, penumbra, and ASPECTS. Serum biomarkers of inflammation, hemostasis, and blood–brain barrier integrity (MMP-9), are measured at admission, 24 and 48 hours from stroke onset. Outcomes comprise early neurological deterioration, hemorrhagic transformation, and functional status (modified Rankin Scale) at discharge and 90 days. Results To date, 46 patients have complete imaging and biomarker data; 90-day follow-up is ongoing. Early observations suggest sequential biomarker assessment is feasible and may complement imaging to better stratify risk in AIS undergoing MT in the extended window (6–24 hours). Perspectives Integrating biomarker dynamics with multimodal CT imaging may enhance early prognostic stratification after extended-window mechanical thrombectomy and support individualized post-acute management in routine stroke care. Conflict of interest This study was funded by the National Agency for Research and Development (NARD) of the Republic of Moldova, research project no. 25.80012.8007.09TC.

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.1197
Primary Topic
Acute Ischemic Stroke Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026YS109 PROGNOSTIC IMPACT OF SEQUENTIAL SERUM BIOMARKERS AND MULTIMODAL CT IMAGING ON CLINICAL OUTCOMES AFTER EXTENDED-WINDOW MECHANICAL THROMBECTOMY IN ACUTE ISCHEMIC STROKE

Olga Gavriliuc, Elena Costru-Tasnic, Teacă Irina, Oxana Grosu et al.
European Stroke Journal
Acute Ischemic Stroke Management
article

ABSTRACT NUMBER: ESOC2026YS109 PROGNOSTIC IMPACT OF SEQUENTIAL SERUM BIOMARKERS AND MULTIMODAL CT IMAGING ON CLINICAL OUTCOMES AFTER EXTENDED-WINDOW MECHANICAL THROMBECTOMY IN ACUTE ISCHEMIC STROKE

Olga Gavriliuc, Elena Costru-Tasnic, Teacă Irina, Oxana Grosu, Cătălina Gutu, Ion Preguza, Adriana Arabadji, Alexandr Dorobet
article en

Abstract

Abstract Background and aims Clinical outcome prognostic of acute ischemic stroke (AIS) patients undergoing mechanical thrombectomy (MT) beyond 6 hours from symptom onset remains challenging. While multimodal CT provides valuable information about brain parenchyma status, biological processes such as inflammation, hemostatic disturbances, and blood–brain barrier disruption may influence outcomes. The role of sequential serum biomarker monitoring in this context is not fully determined. The aim of the study is to assess whether dynamic changes in serum biomarkers, particularly matrix metalloproteinase-9 (MMP-9), alongside multimodal CT imaging, could improve prognostic evaluation of AIS patients undergoing MT in the extended window (6–24 hours). Methods The ongoing prospective observational study includes AIS patients treated with MT at a comprehensive stroke center. Baseline multimodal CT (non-contrast CT, CT angiography, CT perfusion) is used to characterize ischemic core, penumbra, and ASPECTS. Serum biomarkers of inflammation, hemostasis, and blood–brain barrier integrity (MMP-9), are measured at admission, 24 and 48 hours from stroke onset. Outcomes comprise early neurological deterioration, hemorrhagic transformation, and functional status (modified Rankin Scale) at discharge and 90 days. Results To date, 46 patients have complete imaging and biomarker data; 90-day follow-up is ongoing. Early observations suggest sequential biomarker assessment is feasible and may complement imaging to better stratify risk in AIS undergoing MT in the extended window (6–24 hours). Perspectives Integrating biomarker dynamics with multimodal CT imaging may enhance early prognostic stratification after extended-window mechanical thrombectomy and support individualized post-acute management in routine stroke care. Conflict of interest This study was funded by the National Agency for Research and Development (NARD) of the Republic of Moldova, research project no. 25.80012.8007.09TC.

European Stroke JournalVol. 11(Supplement_1)
Nicolae Testemițanu State University of Medicine and Pharmacy (MD), Institute of Dermatology (TH)
Good health and well-being
Openalex Percentile: Top 9%
Acute Ischemic Stroke Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.